New FDA-Approved Diabetes Medicine Might Save Drugmaker

[TexasTowelie]

A new diabetes drug was approved by the Food and Drug Administration Wednesday (February 25). It doesn't sound like breaking news, but for the company behind the drug, it's a pretty big deal.

The French drugmaker Sanofi is now able to sell its drug Toujeo in the United States. And Sanofi is likely thanking its lucky stars.

-snip-

Toujeo is dosed differently than Lantus and is also a long-acting form of insulin.

Sanofi is expected to lose its U.S. patent protection on Lantus later this year. And without any real reason for the health care industry to switch from Lantus to Toujeo, there needs to be some kind of incentive, right?

-snip-

Sanofi hasn't said how much Toujeo will cost, but it's expected to be available in the U.S. in April.

http://www.reporternews.com/newsy/new-fdaapproved-diabetes-medicine-might-save-drugmaker (Abilene Reporter-News)

[In_The_Wind]

1. My Lantas prescription seems terribly expensive.

I hope something that cost less and works comes along soon.

Maybe Toujeo will work for me.